Proceedings from the 2(nd) Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019

For reasons poorly understood, and despite the availability of biological medications blocking IL-1 and IL-6 that have markedly improved overall disease control, children with Systemic Juvenile Idiopathic Arthritis (SJIA) are now increasingly diagnosed with life-threatening chronic complications, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Canna, Scott W., Schulert, Grant S., de Jesus, Adriana, Pickering, Alex, Brunner, Hermine, Gadina, Massimo, Levine, Stewart, Goldbach-Mansky, Raphaela, Boutelle, Jonathan, Sinha, Rashmi, DeBenedetti, Fabrizio, Grom, Alexei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Meeting Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360380/
https://www.ncbi.nlm.nih.gov/pubmed/32664935
http://dx.doi.org/10.1186/s12969-020-00444-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360380/
https://www.ncbi.nlm.nih.gov/pubmed/32664935
http://dx.doi.org/10.1186/s12969-020-00444-7

Ejemplares similares